Naltrexone does not block the subjective effects of oral Delta(9)-tetrahydrocannabinol in humans. (Q51080825)

29 March 2018

title

Naltrexone does not block the subjective effects of oral Delta(9)-tetrahydrocannabinol in humans. (English)

1 reference

29 March 2018

0 references

0 references

0 references

2

1 reference

29 March 2018

author name string

Wachtel SR

series ordinal

1

1 reference

29 March 2018

publication date

1 June 2000

1 reference

29 March 2018

Drug and Alcohol Dependence

published in

1 reference

29 March 2018

volume

59

1 reference

29 March 2018

page(s)

251-260

1 reference

29 March 2018

issue

3

1 reference

29 March 2018

Tolerance to the effect of delta9-tetrahydrocannabinol in mice on intestinal motility, temperature and locomotor activity

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Inhibition of naloxone-induced withdrawal in morphine dependent mice by 1-trans-delta9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

THC does not affect striatal dopamine release: Microdialysis in freely moving rats

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Delta 9-tetrahydrocannabinol enhances presynaptic dopamine efflux in medial prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Strain-specific facilitation of dopamine efflux by Δ9-tetrahydrocannabinol in the nucleus accumbens of rat: An in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Ventral tegmental microinjection of delta 9-tetrahydrocannabinol enhances ventral tegmental somatodendritic dopamine levels but not forebrain dopamine levels: evidence for local neural action by marijuana's psychoactive ingredient

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Reliability, validity, and clinical application of the Visual Analogue Mood Scale.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Assessment of abuse liability of stimulant drugs in humans: a methodological survey

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Marijuana's interaction with brain reward systems: update 1991.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Cannabinoid transmission and reward-related events.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Facilitation of brain stimulation reward by delta 9-tetrahydrocannabinol.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Evaluation of reinforcing capability of delta-9-tetrahydrocannabinol in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Cannabinoid receptor localization in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Neuronal localization of cannabinoid receptors in the basal ganglia of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Morphine-dependent rats: blockade of precipitated abstinence by tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

1-Δ 9 -Tetrahydrocannabinol: Neurochemical and Behavioral Effects in the Mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Cannabinoid inhibition of adenylate cyclase: relative activity of constituents and metabolites of marihuana.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Drug preference and mood in humans: diazepam.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Naloxone-induced or postwithdrawal abstinence signs in ?9-Tetrahydrocannabinol-Tolerant rats

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Failure to obtain "cannabis-directed behavior" and abstinence syndrome in rats chronically treated with cannabis sativa extracts

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Conditioned place preference induced by delta 9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Genetic differences in delta 9-tetrahydrocannabinol-induced facilitation of brain stimulation reward as measured by a rate-frequency curve-shift electrical brain stimulation paradigm in three different rat strains.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Naltrexone, an antagonist for the treatment of heroin dependence. Effects in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Molecular characterization of a peripheral receptor for cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Analgesic Effect of Delta‐9‐Tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Studies of EN-1639A (Naltrexone): A New Narcotic Antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Delta 9-tetrahydrocannabinol facilitates striatal dopaminergic transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Comparative analgesic activity of various naturally occurring cannabinoids in mice and rats

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Self-administration of Δ9-tetrahydrocannabinol by rats

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Effects of body weight levels on Cannabis self-injection

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

The effects of delta 9-tetrahydrocannabinol on potassium-evoked release of dopamine in the rat caudate nucleus: an in vivo electrochemical and in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Antagonism by chlornaltrexamine of some effects of delta 9-tetrahydrocannabinol in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

The effects of morphine and ?-9-tetrahydrocannabinol on motor activity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Naltrexone: disposition, metabolism, and effects after acute and chronic dosing

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

Analgesic properties of the tetrahydrocannabinols, their metabolites, and analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2899%2900127-1

7 January 2021

10.1016/S0376-8716(99)00127-1

Identifiers

DOI

1 reference

29 March 2018

PubMed ID

10812285

1 reference

29 March 2018